Amphithéâtre Maurice Halbwachs, Site Marcelin Berthelot
En libre accès, dans la limite des places disponibles
-

Résumé

Since 2015, the OECD has convened a panel of experts to develop a framework for responsible research and innovation in the field of neurotechnologies. This effort culminated in Recommendation 457 in 2019. In France, this recommendation has been implemented through the development of a Charter, which is poised to become European-wide. Additionally, an interactive toolkit has been recently introduced. Concurrently, the UNESCO International Bioethics Committee released a report in 2021 on the ethical implications of neurotechnologies. These findings serve as the foundation for ongoing efforts to adopt a recommendation in 2025, which will serve as legislative groundwork for member states. We will compare and contrast the approaches of both organizations, in which we have actively participated.

Hervé Chneiweiss

Hervé Chneiweiss

Hervé Chneiweiss (MD-PhD) is a neurologist and neuroscientist, senior scientist at CNRS, he has been involved in neurogenetic research on diseases such as cerebellar ataxias and then the molecular mechanisms involved in astrocyte phenotype and plasticity, and the development of brain tumors, their epigenetic and metabolic drivers. Technical approaches include proteomics, metabolism, epigenetics, cell cultures, animal models, single cell. He has published over 170 original scientific papers (h=55, i10 112). He is currently director of the Neuroscience Paris Seine-IBPS research center (CNRS/Inserm/Sorbonne University). Hervé Chneiweiss is also involved in bioethics, adviser for life sciences and bioethics to the Minister of Research and Technology (2000-02), member of the Scientific Council of the French Parliamentary Office for Scientific and Techniques assesment (2003-16), member of the French National Ethics Committee (2013-17), member and chairman of the UNESCO International Bioethics Committee (2014-21), member of the WHO committee on Human genome governance (2019-21), expert for OECD on neurotechnology (since 2015), and currently as chairman of the Inserm Ethics Committee, EMBL Ethics Board, EBRAINS EESC and co-chair AHEG UNESCO for recommendation on neurotechnologies. Former editor in chief of Medicine/Sciences (2006-16). He has published several books for the general public (latest: Notre cerveau, L’Iconoclaste, 2019).

Intervenant(s)

Hervé Chneiweiss

Research Director au CNRS, Neuro-Oncologist à l'Hôpital Universitaire Pitié-Salpêtrière, Président du comité d'éthique de l'Inserm

Voir aussi

Stéphanie Lacour, chaire Innovation technologique Liliane Bettencourt
La neurotechnologie

Événements

Précédent

Suivant